{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:31:15Z","timestamp":1771270275298,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ymgme.2012.05.016","type":"journal-article","created":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T22:16:32Z","timestamp":1338416192000},"page":"104-110","source":"Crossref","is-referenced-by-count":15,"title":["Can genes influencing muscle function affect the therapeutic response to enzyme replacement therapy (ERT) in late-onset Type II Glycogenosis?"],"prefix":"10.1016","volume":"107","author":[{"given":"Sabrina","family":"Ravaglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"De Filippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pichiecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Ponzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kolsoum","family":"Saeidi Garaghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy Umberto","family":"Poloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Bini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Danesino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2012.05.016_bb0005","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1002\/humu.20745","article-title":"GAA Database Consortium. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating","volume":"29","author":"Kroos","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0010","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Lysosomal storage disease 2 Pompe's disease","volume":"372","author":"Van der Ploeg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2012.05.016_bb0015","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","article-title":"Disease severity in children and adults with Pompe disease related to age and disease duration","volume":"64","author":"Hagemans","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2012.05.016_bb0020","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/ajmg.a.31936","article-title":"Sibling phenotype concordance in classical infantile Pompe disease","volume":"143","author":"Smith","year":"2007","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0025","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"NEJM"},{"key":"10.1016\/j.ymgme.2012.05.016_bb0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10545-010-9201-8","article-title":"Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II","volume":"33","author":"Bembi","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00415-009-5275-3","article-title":"Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial","volume":"257","author":"Strothotte","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0040","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-012-9451-8","article-title":"36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy","author":"Regnery","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0045","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1096\/fasebj.9.11.7649409","article-title":"Genetic determinism of fiber type proportion in human skeletal muscle","volume":"9","author":"Simoneau","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/GIM.0b013e3181d2900e","article-title":"The angiotensin-converting enzyme insertion\/deletion polymorphism modifies the clinical outcome in patients with Pompe disease","volume":"12","author":"De Filippi","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1034\/j.1399-0004.2003.00029.x","article-title":"The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle","volume":"63","author":"Zhang","year":"2003","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0060","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10545-010-9204-5","article-title":"Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response","volume":"33","author":"Ravaglia","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0065","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/35001141","article-title":"The ACE gene and muscle performance","volume":"403","author":"Williams","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2012.05.016_bb0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neulet.2007.06.025","article-title":"Genotype modulators of clinical severity in McArdle disease","volume":"422","author":"Rubio","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0075","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/humu.21526","article-title":"ACTN3 genotype, athletic status, and life course physical capability: meta-analysis of the published literature and findings from nine studies","volume":"32","author":"Alfred","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00421-006-0154-4","article-title":"PPARalpha gene variation and physical performance in Russian athletes","volume":"97","author":"Ahmetov","year":"2006","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mus.20665","article-title":"Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy","volume":"35","author":"Slonim","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2012.05.016_bb0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/mus.21304","article-title":"Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful?","volume":"40","author":"Pichiecchio","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2012.05.016_bb0100","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jnnp.54.3.244","article-title":"Hand-held myometry: reference values","volume":"54","author":"van der Ploeg","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2012.05.016_bb0105","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/humu.20374","article-title":"Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II","volume":"27","author":"Montalvo","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0110","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJM199503163321103","article-title":"A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease","volume":"332","author":"Lindpaintner","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0115","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1469-1809.2006.00385.x","article-title":"No association of the ACTN3 gene R577X polymorphism with endurance performance in Ironman Triathlons","volume":"71","author":"Saunders","year":"2007","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0120","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/hc0802.104535","article-title":"Peroxisome proliferator\u2014activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension","volume":"105","author":"Jamshidi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ymgme.2012.05.016_bb0130","doi-asserted-by":"crossref","first-page":"e15239","DOI":"10.1371\/journal.pone.0015239","article-title":"Fiber type conversion by PGC-1\u03b1 activates lysosomal and autophagosomal biogenesis in both unaffected and Pompe skeletal muscle","volume":"5","author":"Takika","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2012.05.016_bb0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1096-8628(20000501)92:1<77::AID-AJMG13>3.0.CO;2-Q","article-title":"Nonsense mutation of the alpha-actinin-3 gene is not associated with dystrophinopathy","volume":"92","author":"Suminaga","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0140","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.RES.0000223145.74217.e7","article-title":"ACE polymorphisms","volume":"98","author":"Sayed-Tabatabaei","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0145","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2174\/138920111795542606","article-title":"Pompe disease: from new views on pathophysiology to innovative therapeutic strategies","volume":"12","author":"Parenti","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ymgme.2012.05.016_bb0150","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/mus.20896","article-title":"Both type 1 and type 2a muscle fibers can respond to enzyme therapy in Pompe disease","volume":"37","author":"Drost","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2012.05.016_bb0155","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1152\/japplphysiol.91435.2008","article-title":"Strength, power, fiber types, and mRNA expression in trained men and women with different ACTN3 R577X genotypes","volume":"106","author":"Norman","year":"2009","journal-title":"J. Appl. Physiol."},{"issue":"4","key":"10.1016\/j.ymgme.2012.05.016_bb0160","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1152\/physiol.00008.2010","article-title":"A gene for speed: the emerging role of alpha-actinin-3 in muscle metabolism","volume":"25","author":"Berman","year":"2010","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.ymgme.2012.05.016_bb0165","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1152\/japplphysiol.01007.2009","article-title":"Protective role of alpha-actinin-3 in the response to an acute eccentric exercise bout","volume":"109","author":"Vincent","year":"2010","journal-title":"J. Appl. Physiol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212002053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212002053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T07:48:01Z","timestamp":1561794481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719212002053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1096719212002053"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.05.016","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}